Skip to Content
Search Close

Find a patient education sheet

Search Close

Find a patient education sheet

Patient Education Sheet Library

Search Results

Zidesamtinib

Zidesamtinib is used for non-small cell lung cancer (NSCLC).

Treatment Taken by Mouth

Downloads:

Cyclophosphamide Taken by Mouth

Cyclophosphamide is used for many types of cancer.

Treatment Taken by Mouth

Downloads:

Lirafugratinib (Lyrfigtu)

Lirafugratinib is used for a type of bile duct cancer called cholangiocarcinoma (CCA).

Treatment Taken by Mouth

Downloads:

Camizestrant (Etcamah)

Camizestrant is used for breast cancer.

Treatment Taken by Mouth

Downloads:

Brentuximab Vedotin and CHP (Cyclophosphamide, Doxorubicin, Prednisone)

The combination of brentuximab vedotin, cyclophosphamide, doxorubicin, and prednisone (A-CHP) is used for systemic anaplastic…

Treatment Given by Infusion Treatment Taken by Mouth

Downloads:

Daraxonrasib

Daraxonrasib is used for pancreatic cancer.

Treatment Taken by Mouth

Downloads:

Palbociclib and Trastuzumab

The combination of palbociclib and trastuzumab is used for breast cancer.

Treatment Given by Infusion Treatment Given by Injection Treatment Taken by Mouth

Downloads:

Palbociclib, Trastuzumab, and Pertuzumab

The combination of palbociclib, trastuzumab, and pertuzumab is used for breast cancer.

Treatment Given by Infusion Treatment Given by Injection Treatment Taken by Mouth

Downloads:

Capivasertib, Abiraterone, and Prednisone

The combination of capivasertib, abiraterone, and prednisone is used for prostate cancer.

Treatment Taken by Mouth

Downloads:

Tafasitamab, Rituximab, and Lenalidomide

The combination of tafasitamab, rituximab, and lenalidomide (Tafa-R2) is used for follicular lymphoma (FL).

Treatment Given by Infusion Treatment Given by Injection Treatment Taken by Mouth

Downloads:

PES Review Committee

The Patient Education Sheet (PES) Committee is a multidisciplinary team of oncology professionals who guide the development and review of these important resources. This committee ensures that every PES is accurate, clear, and meaningful for patients and caregivers navigating cancer treatment.

Led by NCODA and supported through collaboration with three leading professional organizations—ACCC, HOPA, and ONS—the committee combines expertise from across the oncology care spectrum. Together, they uphold best practices, promote consistency in patient education, and remain committed to improving outcomes through accessible, patient-centered information.

Meet the Committee